Abdominal Aortic Aneurysms Pharmacoepidemiological Studies.

In conclusion, we found an approximately 25% lower risk of rAAA and 20% lower 30-day case fatality in statin-treated patients. Furthermore, we found an almost 20% higher 30-day case fatality following rAAA in ASA treated patients. No association between the use of RAS-blockers and the risk of rAAA or case fatality following rAAA was found. Similarly, we found no association between the use of ASA and the risk of rAAA. PMID: 28552095 [PubMed - in process]
Source: Danish Medical Journal - Category: General Medicine Tags: Dan Med J Source Type: research